Ignite Creation Date:
2025-12-24 @ 11:00 PM
Ignite Modification Date:
2025-12-28 @ 6:50 PM
Study NCT ID:
NCT01157169
Status:
COMPLETED
Last Update Posted:
2020-01-18
First Post:
2010-07-02
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Buprenorphine 8 mg Sublingual Tablets Under Fasting Conditions
Sponsor:
Teva Pharmaceuticals USA
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-08
Start Date Type:
None
Primary Completion Date:
2007-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2007-09
Completion Date Type:
ACTUAL
First Submit Date:
2010-07-02
First Submit QC Date:
None
Study First Post Date:
2010-07-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2010-08-18
Results First Submit QC Date:
None
Results First Post Date:
2010-09-13
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-01-06
Last Update Post Date:
2020-01-18
Last Update Post Date Type:
ACTUAL